This company is no longer active
Resumen de acción IMNP.Q
Immune Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in the development of various therapeutic agents for the treatment of immunologic and inflammatory diseases.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Recompensas
Análisis de riesgos
Competidores de Immune Pharmaceuticals, Inc.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0022 |
| 52 Week High | US$0 |
| 52 Week Low | US$0 |
| Beta | 0 |
| 1 Month Change | -35.94% |
| 3 Month Change | -44.75% |
| 1 Year Change | -68.43% |
| 3 Year Change | -99.92% |
| 5 Year Change | -100.00% |
| Change since IPO | n/a |
Noticias y actualizaciones recientes
No hay actualizaciones
Recent updates
No hay actualizaciones
Rentabilidad de los accionistas
| IMNP.Q | US Biotechs | Mercado US | |
|---|---|---|---|
| 7D | -33.0% | 2.7% | 0.3% |
| 1Y | -68.4% | 2.9% | 24.2% |
Rentabilidad vs. Industria: IMNP.Q underperformed the US Biotechs industry which returned -1.1% over the past year.
Rentabilidad vs. Mercado: IMNP.Q underperformed the US Market which returned -13.6% over the past year.
Volatilidad de los precios
| IMNP.Q volatility | |
|---|---|
| IMNP.Q Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 11.6% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: IMNP.Q's share price has been volatile over the past 3 months.
Volatilidad a lo largo del tiempo: Insufficient data to determine IMNP.Q's volatility change over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2010 | n/a | Gary Rabin | www.immunepharma.com |
Resumen de fundamentos de Immune Pharmaceuticals, Inc.
| Estadísticas fundamentales de IMNP.Q | |
|---|---|
| Capitalización bursátil | US$401.99k |
| Beneficios(TTM) | -US$34.39m |
| Ingresos (TTM) | n/a |
0.0x
Ratio precio-ventas (PS)0.0x
Ratio precio-beneficio (PE)¿Está IMNP.Q sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de IMNP.Q | |
|---|---|
| Ingresos | US$0 |
| Coste de los ingresos | US$0 |
| Beneficio bruto | US$0 |
| Otros gastos | US$34.39m |
| Beneficios | -US$34.39m |
Últimos beneficios comunicados
Sep 30, 2018
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 0 |
| Margen bruto | 0.00% |
| Margen de beneficio neto | 0.00% |
| Ratio deuda/patrimonio | 0.0% |
¿Cómo se ha desempeñado IMNP.Q a largo plazo?
Ver rendimiento histórico y comparativa